Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status

被引:34
|
作者
McCredie, MRE
Dite, GS
Southey, MC
Venter, DJ
Giles, GG
Hopper, JL
机构
[1] Univ Melbourne, Ctr Genet Epidemiol, Carlton, Vic 3053, Australia
[2] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand
[3] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic, Australia
[4] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[5] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia
[6] Canc Council New S Wales, Canc Epidemiol Res Unit, Sydney, NSW, Australia
关键词
breast cancer in young women; epidemiology; oestrogen and progesterone receptor status;
D O I
10.1038/sj.bjc.6601293
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We used data from 765 cases and 564 controls in the population-based Australian Breast Cancer Family Study to investigate whether, in women under the age of 40, the profile of risk factors differed between breast cancer subtypes defined by joint oestrogen and progesterone receptor status. As hypothesised, no significant differences were found.
引用
收藏
页码:1661 / 1663
页数:3
相关论文
共 50 条
  • [41] Oestrogen-receptor status in management of breast cancer in UK
    Mander, BJ
    Heal, K
    Porushotham, AD
    Wishart, GC
    LANCET, 1998, 352 (9121): : 36 - 37
  • [42] Oestrogen receptor status in pre-menopausal breast cancer
    Lioe, TF
    Foster, H
    Hamilton, PW
    Biggart, JD
    JOURNAL OF PATHOLOGY, 1997, 181 : A24 - A24
  • [43] Polychlorinated biphenyls and breast cancer risk by combined estrogen and progesterone receptor status
    Rusiecki J.A.
    Holford T.R.
    Zahm S.H.
    Zheng T.
    European Journal of Epidemiology, 2004, 19 (8) : 793 - 801
  • [44] Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status
    Zhang, Min
    Yang, Hongjian
    Holman, C. D'Arcy J.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (03) : 553 - 563
  • [45] Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status
    Min Zhang
    Hongjian Yang
    C. D’Arcy J. Holman
    Breast Cancer Research and Treatment, 2009, 118 : 553 - 563
  • [46] Polychlorinated biphenyls and breast cancer risk by combined estrogen and progesterone receptor status
    Rusiecki, JA
    Holford, TR
    Zahm, SH
    Zheng, TZ
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2004, 19 (08) : 793 - 801
  • [47] IMPACT OF PROGESTERONE RECEPTOR STATUS ON BREAST CANCER TREATMENT
    Horimoto, Y.
    Nakagawa, T.
    Tokuda, E.
    Arakawa, A.
    Saito, M.
    Kasumi, F.
    ANNALS OF ONCOLOGY, 2010, 21 : 47 - 47
  • [48] Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age
    Britton, JA
    Gammon, MD
    Schoenberg, JB
    Stanford, JL
    Coates, RJ
    Swanson, CA
    Potischman, N
    Malone, KE
    Brogan, DJ
    Daling, JR
    Brinton, LA
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (06) : 507 - 516
  • [49] Discordant Estrogen and Progesterone Receptor Status in Breast Cancer
    Hefti, M. M.
    Hu, R.
    Knoblauch, N.
    Collins, L.
    Tamimi, R. M.
    Beck, A. H.
    CANCER RESEARCH, 2012, 72
  • [50] Reproductive factors and breast cancer risk in relation to hormone receptor and menopausal status in Japanese women
    Kawai, Masaaki
    Kakugawa, Yoichiro
    Nishino, Yoshikazu
    Hamanaka, Yohei
    Ohuchi, Noriaki
    Minami, Yuko
    CANCER SCIENCE, 2012, 103 (10) : 1861 - 1870